Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 2088-2094, April 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hietala, O. A.
Right arrow Articles by O'Brien, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hietala, O. A.
Right arrow Articles by O'Brien, T. G.

Properties of Ornithine Decarboxylase in Human Colorectal Adenocarcinomas1

Oili A. Hietala, Keuk Y. Yum, Janine Pilon, Kevin O'Donnell, Christopher P. Holroyde, Irwin Kline, George A. Reichard, Samuel Litwin, Susan K. Gilmour and Thomas G. O'Brien2

The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104 [O. A. H., K. O., S. K. G., T. G. O.]; The Lankenau Medical Research Center, Philadelphia, Pennsylvania 19151 [K. Y. Y., J. P., C. P. H., I. K., G. A. R.]; and Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [S. L.]

Ornithine decarboxylase (ODC) activity was measured in colon adenocarcinomas and adjacent normal-appearing colon mucosa from a total of 40 patients undergoing surgical resections. The enzyme activity was measured in the presence and absence of GTP, since recent work has demonstrated a GTP-activatable form of ODC in some murine and human tumors. In general, ODC specific activity was higher in adenocarcinomas than in adjacent normal-appearing mucosa. Of greater interest, however, was the finding that 13 of 40 tumors and 3 of 40 mucosae contained a GTP-activatable form of ODC. These are minimal estimates of the proportion of tissues positive for this enzyme form, since a multiple sampling protocol indicated that expression of a GTP-activatable ODC was not uniform throughout a given tumor. Chromatographic analyses of tumor extracts revealed the presence in some tumors of multiple size forms of ODC, only some of which were activated by GTP. Enzyme kinetic data indicated that the multiple forms of ODC can have different affinities for L-ornithine and that GTP can "normalize" the aberrant kinetic properties of these forms.

While there was no statistically significant correlation of the presence of a GTP-activatable ODC with stage of disease, analysis of our data revealed a positive association of a GTP-activatable ODC with tumor site; a much higher percentage of tumors of the cecum contained this ODC isoform than tumors of other colonic segments (64% versus ≤25% for other sites). These results demonstrate (a) the presence of a functionally distinct form of ODC in some human colon adenocarcinomas and (b) a distinct regional distribution of this ODC form within the colon. We suggest this alteration in a key enzyme in the growth-associated pathway of polyamine biosynthesis may play a role in colon tumor progression.

1 This work was supported by NIH Grants ES-01664, CA-06927, and RR-05539, a grant from the Mary L. Smith Charitable Lead Trust, and an appropriation from the Commonwealth of Pennsylvania.

2 To whom requests for reprints should be addressed, at The Wistar Institute of Anatomy and Biology, 36th Street at Spruce, Philadelphia, PA 19104.

Received 8/ 4/89. Revised 12/ 4/89.


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. A. Hobbs, G. Wei, K. DeFeo, B. Paul, C. S. Hayes, and S. K. Gilmour
Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase
Cancer Res., August 15, 2006; 66(16): 8116 - 8122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Y. Chen, J.-L. Shie, and C.-C. Tseng
Gut-enriched Kruppel-like Factor Represses Ornithine Decarboxylase Gene Expression and Functions as Checkpoint Regulator in Colonic Cancer Cells
J. Biol. Chem., November 22, 2002; 277(48): 46831 - 46839.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K.-i. Mafune, Y. Tanaka, K. Mimori, M. Mori, K. Takubo, and M. Makuuchi
Increased Expression of Ornithine Decarboxylase Messenger RNA in Human Esophageal Carcinoma
Clin. Cancer Res., December 1, 1999; 5(12): 4073 - 4078.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.